Login to Your Account



Clinic Roundup


Monday, September 19, 2011
Trius Therapeutics Inc., of San Diego, completed enrollment in the first of two Phase III trials of tedizolid phosphate (formerly torezolid) in acute bacterial skin infection.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription